Structural Insights into the Molecular Recognition between Cerebral Cavernous Malformation 2 and Mitogen-Activated Protein Kinase Kinase Kinase 3

Structure

Volumn 23, Issue 6, 2015, Pages 1087-1096

  Wang, Xiaoyan ^a,b   Hou, Yanjie ^a   Deng, Kai ^a,b   Zhang, Ying ^a   Wang, Da Cheng ^a   Ding, Jingjin ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b HUBEI UNIVERSITY OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CEREBRAL CAVERNOUS MALFORMATION 2; MITOGEN ACTIVATED PROTEIN KINASE KINASE KINASE 3; UNCLASSIFIED DRUG; CARRIER PROTEIN; CCM2 PROTEIN, HUMAN; MAP3K3 PROTEIN, HUMAN; PROTEIN BINDING;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; BINDING SITE; BIOCHEMICAL ANALYSIS; CARBOXY TERMINAL SEQUENCE; HYDROPHOBICITY; MOLECULAR RECOGNITION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN INTERACTION; PROTEIN STRUCTURE; AMINO ACID SEQUENCE; CHEMICAL STRUCTURE; CHEMISTRY; HUMAN; METABOLISM; MOLECULAR GENETICS; PROTEIN DOMAIN; PROTEIN FOLDING;

AMINO ACID SEQUENCE; CARRIER PROTEINS; HUMANS; MAP KINASE KINASE KINASE 3; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN FOLDING; PROTEIN INTERACTION DOMAINS AND MOTIFS;

EID: 84930272125     PISSN: 09692126     EISSN: 18784186     Source Type: Journal    
DOI: 10.1016/j.str.2015.04.003     Document Type: Article

References (41)

1. P.D. Adams, P.V. Afonine, G. Bunkoczi, V.B. Chen, I.W. Davis, N. Echols, J.J. Headd, L.W. Hung, G.J. Kapral, and R.W. Grosse-Kunstleve PHENIX: a comprehensive Python-based system for macromolecular structure solution Acta Crystallogr. D Biol. Crystallogr. 66 2010 213 221
2. R.P. Bhattacharyya, A. Remenyi, B.J. Yeh, and W.A. Lim Domains, motifs, and scaffolds: the role of modular interactions in the evolution and wiring of cell signaling circuits Annu. Rev. Biochem. 75 2006 655 680
3. A.L. Borikova, C.F. Dibble, N. Sciaky, C.M. Welch, A.N. Abell, S. Bencharit, and G.L. Johnson Rho kinase inhibition rescues the endothelial cell cerebral cavernous malformation phenotype J. Biol. Chem. 285 2010 11760 11764
4. V.B. Chen, W.B. Arendall 3rd, J.J. Headd, D.A. Keedy, R.M. Immormino, G.J. Kapral, L.W. Murray, J.S. Richardson, and D.C. Richardson MolProbity: all-atom structure validation for macromolecular crystallography Acta Crystallogr. D Biol. Crystallogr. 66 2010 12 21
5. R. Chenna, H. Sugawara, T. Koike, R. Lopez, T.J. Gibson, D.G. Higgins, and J.D. Thompson Multiple sequence alignment with the Clustal series of programs Nucleic Acids Res. 31 2003 3497 3500
6. B. Costa, M.J. Kean, V. Ast, J.D. Knight, A. Mett, Z. Levy, D.F. Ceccarelli, B.G. Badillo, R. Eils, and R. Konig STK25 protein mediates TrkA and CCM2 protein-dependent death in pediatric tumor cells of neural origin J. Biol. Chem. 287 2012 29285 29289
7. L.E. Crose, T.L. Hilder, N. Sciaky, and G.L. Johnson Cerebral cavernous malformation 2 protein promotes smad ubiquitin regulatory factor 1-mediated RhoA degradation in endothelial cells J. Biol. Chem. 284 2009 13301 13305
8. C. Denier, S. Goutagny, P. Labauge, V. Krivosic, M. Arnoult, A. Cousin, A.L. Benabid, J. Comoy, P. Frerebeau, and B. Gilbert Mutations within the MGC4607 gene cause cerebral cavernous malformations Am. J. Hum. Genet. 74 2004 326 337
9. J. Ding, X. Wang, D.F. Li, Y. Hu, Y. Zhang, and D.C. Wang Crystal structure of human programmed cell death 10 complexed with inositol-(1,3,4,5)-tetrakisphosphate: a novel adaptor protein involved in human cerebral cavernous malformation Biochem. Biophys. Res. Commun. 399 2010 587 592
10. E.J. Dodson, M. Winn, and A. Ralph Collaborative Computational Project, number 4: providing programs for protein crystallography Methods Enzymol. 277 1997 620 633
11. P. Emsley, B. Lohkamp, W.G. Scott, and K. Cowtan Features and development of Coot Acta Crystallogr. D Biol. Crystallogr. 66 2010 486 501
12. E. Faurobert, and C. Albiges-Rizo Recent insights into cerebral cavernous malformations: a complex jigsaw puzzle under construction FEBS J. 277 2010 1084 1096
13. O.S. Fisher, R. Zhang, X. Li, J.W. Murphy, B. Demeler, and T.J. Boggon Structural studies of cerebral cavernous malformations 2 (CCM2) reveal a folded helical domain at its C-terminus FEBS Lett. 587 2013 272 277
14. D.C. Flynn Adaptor proteins Oncogene 20 2001 6270 6272
15. M.C. Good, J.G. Zalatan, and W.A. Lim Scaffold proteins: hubs for controlling the flow of cellular information Science 332 2011 680 686
16. L. Harel, B. Costa, M. Tcherpakov, M. Zapatka, A. Oberthuer, L.M. Hansford, M. Vojvodic, Z. Levy, Z.Y. Chen, and F.S. Lee CCM2 mediates death signaling by the TrkA receptor tyrosine kinase Neuron 63 2009 585 591
17. T.L. Hilder, M.H. Malone, S. Bencharit, J. Colicelli, T.A. Haystead, G.L. Johnson, and C.C. Wu Proteomic identification of the cerebral cavernous malformation signaling complex J. Proteome Res. 6 2007 4343 4355
18. L. Holm, and C. Sander Dali: a network tool for protein structure comparison Trends Biochem. Sci. 20 1995 478 480
19. B. Kleaveland, X. Zheng, J.J. Liu, Y. Blum, J.J. Tung, Z. Zou, S.M. Sweeney, M. Chen, L. Guo, and M.M. Lu Regulation of cardiovascular development and integrity by the heart of glass-cerebral cavernous malformation protein pathway Nat. Med. 15 2009 169 176
20. P. Labauge, C. Denier, F. Bergametti, and E. Tournier-Lasserve Genetics of cavernous angiomas Lancet Neurol. 6 2007 237 244
21. X. Li, R. Zhang, H. Zhang, Y. He, W. Ji, W. Min, and T.J. Boggon Crystal structure of CCM3, a cerebral cavernous malformation protein critical for vascular integrity J. Biol. Chem. 285 2010 24099 24107
22. C.L. Liquori, M.J. Berg, A.M. Siegel, E. Huang, J.S. Zawistowski, T. Stoffer, D. Verlaan, F. Balogun, L. Hughes, and T.P. Leedom Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations Am. J. Hum. Genet. 73 2003 1459 1464
23. C.L. Liquori, M.J. Berg, F. Squitieri, T.P. Leedom, L. Ptacek, E.W. Johnson, and D.A. Marchuk Deletions in CCM2 are a common cause of cerebral cavernous malformations Am. J. Hum. Genet. 80 2007 69 75
24. L. Pan, J. Yan, L. Wu, and M. Zhang Assembling stable hair cell tip link complex via multidentate interactions between harmonin and cadherin 23 Proc. Natl. Acad. Sci. USA 106 2009 5575 5580
25. C.Q. Pan, M. Sudol, M. Sheetz, and B.C. Low Modularity and functional plasticity of scaffold proteins as p(l)acemakers in cell signaling Cell Signal. 24 2012 2143 2165
26. H.H. Park, Y.C. Lo, S.C. Lin, L. Wang, J.K. Yang, and H. Wu The death domain superfamily in intracellular signaling of apoptosis and inflammation Annu. Rev. Immunol. 25 2007 561 586
27. X. Robert, and P. Gouet Deciphering key features in protein structures with the new ENDscript server Nucleic Acids Res. 42 2014 W320 W324
28. J.N. Rosen, V.M. Sogah, L.Y. Ye, and J.D. Mably ccm2-like is required for cardiovascular development as a novel component of the Heg-CCM pathway Dev. Biol. 376 2013 74 85
29. Z. Songyang, S.E. Shoelson, M. Chaudhuri, G. Gish, T. Pawson, W.G. Haser, F. King, T. Roberts, S. Ratnofsky, and R.J. Lechleider SH2 domains recognize specific phosphopeptide sequences Cell 72 1993 767 778
30. R.A. Stockton, R. Shenkar, I.A. Awad, and M.H. Ginsberg Cerebral cavernous malformations proteins inhibit Rho kinase to stabilize vascular integrity J. Exp. Med. 207 2010 881 896
31. M.T. Uhlik, A.N. Abell, N.L. Johnson, W. Sun, B.D. Cuevas, K.E. Lobel-Rice, E.A. Horne, M.L. Dell'Acqua, and G.L. Johnson Rac-MEKK3-MKK3 scaffolding for p38 MAPK activation during hyperosmotic shock Nat. Cell Biol. 5 2003 1104 1110
32. K. Voss, S. Stahl, E. Schleider, S. Ullrich, J. Nickel, T.D. Mueller, and U. Felbor CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations Neurogenetics 8 2007 249 256
33. X. Wang, J. Ding, and D. Wang Crystallization and preliminary X-ray analysis of the C-terminal domain of CCM2, part of a novel adaptor protein involved in cerebral cavernous malformations Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 68 2012 683 686
34. K.J. Whitehead, A.C. Chan, S. Navankasattusas, W. Koh, N.R. London, J. Ling, A.H. Mayo, S.G. Drakos, C.A. Jones, and W. Zhu The cerebral cavernous malformation signaling pathway promotes vascular integrity via Rho GTPases Nat. Med. 15 2009 177 184
35. C. Wu, E.M. Haynes, S.B. Asokan, J.M. Simon, N.E. Sharpless, A.S. Baldwin, I.J. Davis, G.L. Johnson, and J.E. Bear Loss of Arp2/3 induces an NF-kappaB-dependent, nonautonomous effect on chemotactic signaling J. Cell Biol. 203 2013 907 916
36. X. Xu, X. Wang, Y. Zhang, D.C. Wang, and J. Ding Structural basis for the unique heterodimeric assembly between cerebral cavernous malformation 3 and germinal center kinase III Structure 21 2013 1059 1066
37. J.S. Zawistowski, L. Stalheim, M.T. Uhlik, A.N. Abell, B.B. Ancrile, G.L. Johnson, and D.A. Marchuk CCM1 and CCM2 protein interactions in cell signaling: implications for cerebral cavernous malformations pathogenesis Hum. Mol. Genet. 14 2005 2521 2531
38. M. Zhang, L. Dong, Z. Shi, S. Jiao, Z. Zhang, W. Zhang, G. Liu, C. Chen, M. Feng, and Q. Hao Structural mechanism of CCM3 heterodimerization with GCKIII kinases Structure 21 2013 680 688
39. X. Zheng, C. Xu, A.O. Smith, A.N. Stratman, Z. Zou, B. Kleaveland, L. Yuan, C. Didiku, A. Sen, and X. Liu Dynamic regulation of the cerebral cavernous malformation pathway controls vascular stability and growth Dev. Cell 23 2012 342 355
40. X. Zhou, Y. Izumi, M.B. Burg, and J.D. Ferraris Rac1/osmosensing scaffold for MEKK3 contributes via phospholipase C-gamma1 to activation of the osmoprotective transcription factor NFAT5 Proc. Natl. Acad. Sci. USA 108 2011 12155 12160
41. Z. Zhou, D.R. Rawnsley, L.M. Goddard, W. Pan, X.J. Cao, Z. Jakus, H. Zheng, J. Yang, J.S. Arthur, and K.J. Whitehead The cerebral cavernous malformation pathway controls cardiac development via regulation of endocardial MEKK3 signaling and KLF expression Dev. Cell 32 2015 168 180